Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease

被引：0
|
作者：
Koutroubakis, IE
Theodoropoulou, A
Xidakis, C
Sfiridaki, A
Notas, G
Kolios, G
Kouroumalis, E
机构：
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A206 / A206
页数：1
相关论文
共 50 条
  • [31] Soluble CD40 ligand: a novel biomarker in the pathogenesis of periodontal disease
    Chaturvedi, Rashi
    Gupta, Mili
    Jain, Ashish
    Das, Tarun
    Prashar, Savita
    CLINICAL ORAL INVESTIGATIONS, 2015, 19 (01) : 45 - 52
  • [32] Soluble CD40 ligand: a novel biomarker in the pathogenesis of periodontal disease
    Rashi Chaturvedi
    Mili Gupta
    Ashish Jain
    Tarun Das
    Savita Prashar
    Clinical Oral Investigations, 2015, 19 : 45 - 52
  • [33] INVOLVEMENT OF THE CD40/CD40 LIGAND PATHWAY IN COELIAC DISEASE
    Di Sabatino, A.
    Rovedatti, L.
    Cantoro, L.
    Vetrano, S.
    Biancheri, P.
    Cazzola, P.
    Strada, E.
    Broglia, F.
    Danese, S.
    Corazza, G. R.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S50 - S50
  • [34] The contribution of CD40/CD40L axis in inflammatory bowel disease: an update
    Senhaji, Nezha
    Kojok, Kevin
    Darif, Youssef
    Fadainia, Christophe
    Zaid, Younes
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [35] Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production
    Liu, ZJ
    Colpaert, S
    D'Haens, GR
    Kasran, A
    de Boer, M
    Rutgeerts, P
    Geboes, K
    Ceuppens, JL
    JOURNAL OF IMMUNOLOGY, 1999, 163 (07): : 4049 - 4057
  • [36] Pentoxifylline decreases soluble CD40 ligand concentration and CD40 gene expression in coronary artery disease patients
    Shamsara, Jamal
    Mohammadpour, Amir Hooshang
    Behravan, Javad
    Falsoleiman, Homa
    Ramezani, Mohammad
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2012, 34 (03) : 523 - 529
  • [37] Diurnal variation of soluble CD40 ligand in patients with acute coronary syndrome. Soluble CD40 ligand and diurnal variation
    Dominguez-Rodriguez, Alberto
    Abreu-Gonzalez, Pedro
    Garcia-Gonzalez, Martin J.
    Kaski, Juan Carlos
    THROMBOSIS RESEARCH, 2009, 123 (04) : 617 - 621
  • [38] An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions
    Blumberg, Neil
    Gettings, Kelly F.
    Turner, Chantal
    Heal, Joanna M.
    Phipps, Richard P.
    TRANSFUSION, 2006, 46 (10) : 1813 - 1821
  • [39] The Relation between CD40 Ligand and Coronary Artery Disease
    Balta, Sevket
    Ozturk, Cengiz
    CARDIOLOGY, 2015, 131 (02) : 107 - 108
  • [40] Soluble CD40 ligand in acute coronary syndromes
    Heeschen, C
    Dimmeler, S
    Hamm, CW
    van den Brand, MJ
    Boersma, E
    Zeiher, AM
    Simoons, ML
    CAPTURE Study Investigators
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12): : 1104 - 1111
12345